Prolactin supplementation to culture medium improves β-cell survival

Toshiyuki Yamamoto, Atsuyoshi Mita, Camillo Ricordi, Shari Messinger, Atsushi Miki, Yasunaru Sakuma, Francesca Timoneri, Scott Barker, Alessia Fornoni, Ruth Molano, Luca A Inverardi, Antonello Pileggi, Hirohito Ichii

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

OBJECTIVES.: Recent studies demonstrated that prolactin (PRL) has beneficial effects on β cells for islet transplantation. We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation. MATERIALS AND METHODS.: Each human islet isolated from 14 deceased multiorgan donors was cultured in Miami modified media-1 supplemented with or without rhPRL (500 μg/L) for 48 hr. β-Cell survival and proliferation (BrdU and Ki-67) were determined by laser scanning cytometry. The cytoprotective effects of rhPRL against noxious stimuli were assessed by flow cytometry (tetramethylrhodamine ethyl ester). Cytokine/chemokine and tissue factor productions were measured in vitro, and islet potency was assessed in vivo in diabetic immunodeficient mice. RESULTS.: β-Cell survival during culture was 37% higher in the rhPRL group than in control (P=0.029). rhPRL protected β cells in vitro from cytokines, Nitric oxide donor, and H2O 2. The exposure to rhPRL did not affect human β-cell proliferation with our protocol. rhPRL treatment did not alter cytokine/chemokine and tissue factor production in vitro or affected human islet functionality in vivo: recipient mice achieved normoglycemia with a comparable tempo, whereas loss of graft function was observed in two of the seven mice in the control group and in none of the rhPRL group (p=n.s.). CONCLUSION.: rhPRL supplementation to islet culture media improved human β-cell-specific survival without altering islet quality. Addition of rhPRL to cultured islets may grant a more viable β-cell mass in culture. The development of β-cell cytoprotective strategies will be of assistance in improving islet transplantation outcomes.

Original languageEnglish
Pages (from-to)1328-1335
Number of pages8
JournalTransplantation
Volume89
Issue number11
DOIs
StatePublished - Jun 15 2010

Fingerprint

Prolactin
Culture Media
Cell Survival
Islets of Langerhans Transplantation
Thromboplastin
Cytokines
Chemokines
Laser Scanning Cytometry
Cell Proliferation
Control Groups
Nitric Oxide Donors
Cell Transplantation
Bromodeoxyuridine
Flow Cytometry
Esters
Transplants
In Vitro Techniques
Therapeutics

Keywords

  • Chemokine.
  • Cytokine
  • Islet
  • Prolactin
  • Transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Prolactin supplementation to culture medium improves β-cell survival. / Yamamoto, Toshiyuki; Mita, Atsuyoshi; Ricordi, Camillo; Messinger, Shari; Miki, Atsushi; Sakuma, Yasunaru; Timoneri, Francesca; Barker, Scott; Fornoni, Alessia; Molano, Ruth; Inverardi, Luca A; Pileggi, Antonello; Ichii, Hirohito.

In: Transplantation, Vol. 89, No. 11, 15.06.2010, p. 1328-1335.

Research output: Contribution to journalArticle

Yamamoto, T, Mita, A, Ricordi, C, Messinger, S, Miki, A, Sakuma, Y, Timoneri, F, Barker, S, Fornoni, A, Molano, R, Inverardi, LA, Pileggi, A & Ichii, H 2010, 'Prolactin supplementation to culture medium improves β-cell survival', Transplantation, vol. 89, no. 11, pp. 1328-1335. https://doi.org/10.1097/TP.0b013e3181d98af1
Yamamoto, Toshiyuki ; Mita, Atsuyoshi ; Ricordi, Camillo ; Messinger, Shari ; Miki, Atsushi ; Sakuma, Yasunaru ; Timoneri, Francesca ; Barker, Scott ; Fornoni, Alessia ; Molano, Ruth ; Inverardi, Luca A ; Pileggi, Antonello ; Ichii, Hirohito. / Prolactin supplementation to culture medium improves β-cell survival. In: Transplantation. 2010 ; Vol. 89, No. 11. pp. 1328-1335.
@article{565f899f9a3c45c58080d0e09bcf28c6,
title = "Prolactin supplementation to culture medium improves β-cell survival",
abstract = "OBJECTIVES.: Recent studies demonstrated that prolactin (PRL) has beneficial effects on β cells for islet transplantation. We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation. MATERIALS AND METHODS.: Each human islet isolated from 14 deceased multiorgan donors was cultured in Miami modified media-1 supplemented with or without rhPRL (500 μg/L) for 48 hr. β-Cell survival and proliferation (BrdU and Ki-67) were determined by laser scanning cytometry. The cytoprotective effects of rhPRL against noxious stimuli were assessed by flow cytometry (tetramethylrhodamine ethyl ester). Cytokine/chemokine and tissue factor productions were measured in vitro, and islet potency was assessed in vivo in diabetic immunodeficient mice. RESULTS.: β-Cell survival during culture was 37{\%} higher in the rhPRL group than in control (P=0.029). rhPRL protected β cells in vitro from cytokines, Nitric oxide donor, and H2O 2. The exposure to rhPRL did not affect human β-cell proliferation with our protocol. rhPRL treatment did not alter cytokine/chemokine and tissue factor production in vitro or affected human islet functionality in vivo: recipient mice achieved normoglycemia with a comparable tempo, whereas loss of graft function was observed in two of the seven mice in the control group and in none of the rhPRL group (p=n.s.). CONCLUSION.: rhPRL supplementation to islet culture media improved human β-cell-specific survival without altering islet quality. Addition of rhPRL to cultured islets may grant a more viable β-cell mass in culture. The development of β-cell cytoprotective strategies will be of assistance in improving islet transplantation outcomes.",
keywords = "Chemokine., Cytokine, Islet, Prolactin, Transplantation",
author = "Toshiyuki Yamamoto and Atsuyoshi Mita and Camillo Ricordi and Shari Messinger and Atsushi Miki and Yasunaru Sakuma and Francesca Timoneri and Scott Barker and Alessia Fornoni and Ruth Molano and Inverardi, {Luca A} and Antonello Pileggi and Hirohito Ichii",
year = "2010",
month = "6",
day = "15",
doi = "10.1097/TP.0b013e3181d98af1",
language = "English",
volume = "89",
pages = "1328--1335",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Prolactin supplementation to culture medium improves β-cell survival

AU - Yamamoto, Toshiyuki

AU - Mita, Atsuyoshi

AU - Ricordi, Camillo

AU - Messinger, Shari

AU - Miki, Atsushi

AU - Sakuma, Yasunaru

AU - Timoneri, Francesca

AU - Barker, Scott

AU - Fornoni, Alessia

AU - Molano, Ruth

AU - Inverardi, Luca A

AU - Pileggi, Antonello

AU - Ichii, Hirohito

PY - 2010/6/15

Y1 - 2010/6/15

N2 - OBJECTIVES.: Recent studies demonstrated that prolactin (PRL) has beneficial effects on β cells for islet transplantation. We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation. MATERIALS AND METHODS.: Each human islet isolated from 14 deceased multiorgan donors was cultured in Miami modified media-1 supplemented with or without rhPRL (500 μg/L) for 48 hr. β-Cell survival and proliferation (BrdU and Ki-67) were determined by laser scanning cytometry. The cytoprotective effects of rhPRL against noxious stimuli were assessed by flow cytometry (tetramethylrhodamine ethyl ester). Cytokine/chemokine and tissue factor productions were measured in vitro, and islet potency was assessed in vivo in diabetic immunodeficient mice. RESULTS.: β-Cell survival during culture was 37% higher in the rhPRL group than in control (P=0.029). rhPRL protected β cells in vitro from cytokines, Nitric oxide donor, and H2O 2. The exposure to rhPRL did not affect human β-cell proliferation with our protocol. rhPRL treatment did not alter cytokine/chemokine and tissue factor production in vitro or affected human islet functionality in vivo: recipient mice achieved normoglycemia with a comparable tempo, whereas loss of graft function was observed in two of the seven mice in the control group and in none of the rhPRL group (p=n.s.). CONCLUSION.: rhPRL supplementation to islet culture media improved human β-cell-specific survival without altering islet quality. Addition of rhPRL to cultured islets may grant a more viable β-cell mass in culture. The development of β-cell cytoprotective strategies will be of assistance in improving islet transplantation outcomes.

AB - OBJECTIVES.: Recent studies demonstrated that prolactin (PRL) has beneficial effects on β cells for islet transplantation. We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation. MATERIALS AND METHODS.: Each human islet isolated from 14 deceased multiorgan donors was cultured in Miami modified media-1 supplemented with or without rhPRL (500 μg/L) for 48 hr. β-Cell survival and proliferation (BrdU and Ki-67) were determined by laser scanning cytometry. The cytoprotective effects of rhPRL against noxious stimuli were assessed by flow cytometry (tetramethylrhodamine ethyl ester). Cytokine/chemokine and tissue factor productions were measured in vitro, and islet potency was assessed in vivo in diabetic immunodeficient mice. RESULTS.: β-Cell survival during culture was 37% higher in the rhPRL group than in control (P=0.029). rhPRL protected β cells in vitro from cytokines, Nitric oxide donor, and H2O 2. The exposure to rhPRL did not affect human β-cell proliferation with our protocol. rhPRL treatment did not alter cytokine/chemokine and tissue factor production in vitro or affected human islet functionality in vivo: recipient mice achieved normoglycemia with a comparable tempo, whereas loss of graft function was observed in two of the seven mice in the control group and in none of the rhPRL group (p=n.s.). CONCLUSION.: rhPRL supplementation to islet culture media improved human β-cell-specific survival without altering islet quality. Addition of rhPRL to cultured islets may grant a more viable β-cell mass in culture. The development of β-cell cytoprotective strategies will be of assistance in improving islet transplantation outcomes.

KW - Chemokine.

KW - Cytokine

KW - Islet

KW - Prolactin

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=77953362498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953362498&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3181d98af1

DO - 10.1097/TP.0b013e3181d98af1

M3 - Article

C2 - 20357700

AN - SCOPUS:77953362498

VL - 89

SP - 1328

EP - 1335

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 11

ER -